CARY STREET PARTNERS INVESTMENT ADVISORY LLC
Position in BBIO — BridgeBio Pharma, Inc.
CIK 1766904
RICHMOND, VA
Position in BBIO
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$35,600
+$20,230 QoQ
Shares Held
478
+130.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#381
of 469 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CARY STREET PARTNERS INVESTMENT ADVISORY LLC holds $764,016 across 7 Biotechnology names. BBIO ranks #3 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
688 | $428,990 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
555 | $275,679 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
This page
|
478 | $35,600 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
173 | $13,539 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
25 | $7,124 | |
| 6 | FTRE |
Fortrea Holdings Inc.
|
134 | $2,331 | |
| 7 | PRTA |
Prothena Corp Public Ltd Co
|
77 | $753 |
All Filings in BBIO
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,600 | 478 | Shares | Other | 2026-07-17 | |
| 2026-03-31 | $15,370 | 207 | Shares | Other | 2026-04-29 | |
| 2025-12-31 | $43,369 | 567 | Shares | Other | 2026-02-09 | |
| 2025-09-30 | $3,063 | 59 | Shares | Other | 2025-11-10 | |
| 2025-06-30 | $1,899 | 44 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $1,036 | 30 | Shares | Other | 2025-05-09 | |
| No filing history on record for this holder in this stock. | ||||||